Inactive Instrument

Transcripts Adamas Pharmaceuticals, Inc.

Stocks

ADMS

US00548A1060

Biotechnology & Medical Research

Transcripts

21-08-09	Adamas Pharmaceuticals, Inc., Q2 2021 Earnings Call, Aug 09, 2021
21-05-11	Adamas Pharmaceuticals, Inc. Presents at BofA Securities 2021 Virtual Health Care Conference, May-11-2021 11:45 AM
21-05-10	Adamas Pharmaceuticals, Inc., Q1 2021 Earnings Call, May 10, 2021
21-03-02	Adamas Pharmaceuticals, Inc. Presents at Cowen 41st Annual Health Care Conference, Mar-02-2021 02:50 PM
21-02-23	Adamas Pharmaceuticals, Inc., Q4 2020 Earnings Call, Feb 23, 2021
21-02-01	Adamas Pharmaceuticals, Inc. - Special Call
21-01-13	Adamas Pharmaceuticals, Inc. Provides Revenues Guidance for the Fourth Quarter and Full Year 2020	CI
21-01-11	Adamas Pharmaceuticals, Inc. Presents at H.C. Wainwright BioConnect 2021 Conference, Jan-11-2021 06:00 AM
20-11-05	Adamas Pharmaceuticals, Inc., Q3 2020 Earnings Call, Nov 05, 2020
20-08-06	Adamas Pharmaceuticals, Inc., Q2 2020 Earnings Call, Aug 06, 2020
20-05-07	Adamas Pharmaceuticals, Inc., Q1 2020 Earnings Call, May 07, 2020
20-02-25	Adamas Pharmaceuticals, Inc., Q4 2019 Earnings Call, Feb 25, 2020
20-01-08	Adamas Pharmaceuticals, Inc. Provides Preliminary Consolidated Sales Guidance for GOCOVRI for the Fourth Quarter and Full Year Ended December 31, 2019; Expects to Engage with the FDA in the First Half of 2020 to Discuss a Potential Regulatory Pathway for ADS-5102 for Multiple Sclerosis Patients	CI
19-11-07	Adamas Pharmaceuticals, Inc., Q3 2019 Earnings Call, Nov 07, 2019
19-08-08	Adamas Pharmaceuticals, Inc., Q2 2019 Earnings Call, Aug 08, 2019
19-05-15	Adamas Pharmaceuticals, Inc. Presents at Bank of America Merrill Lynch 2019 Healthcare Conference, May-15-2019 10:40 AM
19-05-09	Adamas Pharmaceuticals, Inc., Q1 2019 Earnings Call, May 09, 2019
19-03-04	Adamas Pharmaceuticals, Inc., Q4 2018 Earnings Call, Mar 04, 2019
19-01-06	Adamas Pharmaceuticals, Inc. Provides Preliminary Consolidated Sales Guidance for GOCOVRI for the Fourth Quarter and Full Year Ended December 31, 2018; Expects the Completion of Enrollment for the Phase 3 Inroads Study of ADS-5102	CI
18-11-14	Adamas Pharmaceuticals, Inc. Presents at 27th Annual Credit Suisse Healthcare Conference, Nov-14-2018 02:50 PM
18-11-01	Adamas Pharmaceuticals, Inc., Q3 2018 Earnings Call, Nov 01, 2018
18-08-02	Adamas Pharmaceuticals, Inc., Q2 2018 Earnings Call, Aug 02, 2018
18-05-16	Adamas Pharmaceuticals, Inc. Presents at Bank of America Merrill Lynch 2018 Healthcare Conference, May-16-2018 01:40 PM
18-05-08	Adamas Pharmaceuticals, Inc. Presents at 43rd annual Deutsche Bank Healthcare Conference, May-08-2018 02:50 PM
18-05-03	Adamas Pharmaceuticals, Inc., Q1 2018 Earnings Call, May 03, 2018